The company's S-1 lays the groundwork for what is widely expected to be one of the largest initial public offerings of the year, second only to Uber's IPO in May. It's also...Technologyread more
Fraud investigator Harry Markopolos' accusations extended beyond GE's management to actuaries, auditors and analysts who he claims overlooked billions in liabilities.Marketsread more
Trump's tweet comes a day after Apple put out a press release describing the money it spends on U.S.-based suppliers and vendors.Technologyread more
CNBC combed through Wall Street research to see which stocks are still a buy after their earnings reports.Marketsread more
President Donald Trump held a call on Wednesday with the CEOs of three major U.S. banks, according to people with knowledge of the situation.Marketsread more
Despite aggressive strides, Waymo needs one thing before their self-driving cars become a seriously useful transportation system: people. We talked to the ones closest to it.Technologyread more
Scientists say the smoke plumes, filled with megatons of tiny, harmful particles, could travel to other areas of the world and cause serious respiratory problems for people.Weather & Natural Disastersread more
Some Weight Watchers loyalists applaud Kurbo by WW. But nutritionists worry Kurbo promotes an unhealthy relationship with food during an especially impressionable time.Health and Scienceread more
Benefits from what President Trump called "the biggest reform of all time" to the tax code have dwindled to a faint breeze just 20 months after its enactment, writes John...Politicsread more
Epstein, 66, was found in his cell in Manhattan federal lockup Saturday morning and transferred to a nearby hospital, where he was subsequently pronounced dead.Politicsread more
Air travelers faced delays at U.S. airports on Friday afternoon after a computer issue snarled processing of international arrivals.Airlinesread more
There are few things CNBC's Jim Cramer likes more than a broad-based rally, and often times, unknown stocks are the ones driving the gains.
"At a time when so many stocks have come up so far so fast, I think it's worth calling attention to these stealth out-performers that, in many ways, are far more emblematic of this advance than a Facebook or a Netflix or an Alphabet," the "Mad Money " host said.
One such stock is LKQ Corporation, a little-known $11 billion auto parts giant that distributes alternative and specialty car parts. Many of its products are recycled from car accidents.
With shares up 33 percent since April, LKQ has been quietly building up its business, making a series of strong, international acquisitions and integrating them well.
The company has purchased a number of European auto parts players just in time for the continent-wide economic rebound, giving it the scale and bargaining power to negotiate with suppliers.
"The bottom line? I love this kind of story. It's meat and potatoes. LKQ is exactly the kind of quiet, unheralded, under-the-radar winner that makes this market so powerful. I think it deserves more credit. That's why I'm sponsoring it and why I'm pounding the table," Cramer said. "Given the strength of the numbers and the stock's cheapness, I bet the completely anonymous LKQ has a lot more room to run. Sure, I'd like it on a pullback. That'll give you a chance to get to know the company, not just the initials, before you take the plunge."
It's easy to forget that stocks can trade, and trade viciously, on the trends of supply and demand, Cramer said on Thursday.
"Like any other market, when there's too much demand, stocks go higher, and when there's too much supply ... stocks go lower," Cramer said. "Today, you could see those supply and demand dynamics in action ... and that led to some very difficult trading. "
When it comes to demand, the technology sector is a clear leader, Cramer said. Investors are hungry for everything from semiconductor and gaming stocks to those tied to e-commerce, social media and software.
Supply is still rife in the struggling retail sector, in which companies are slashing prices to avoid being crushed by high-volume online retailers like Amazon.
Domino's Pizza President and CEO Patrick Doyle told CNBC on Thursday that pizza delivery is getting a major reboot.
"We've been talking about natural voice as how we think people are going to interact with technology for a while. We started investing in it three or four years ago," Doyle told Cramer in an exclusive interview.
Now, Doyle's starting to see his pizza-meets-tech giant's investments bear fruit, he told Cramer.
"Alexa, now, of our AnyWare suite of products, has been really the strongest for us in terms of total number of orders. That keeps growing, " the CEO said. "Google Home's doing well. We're looking at other ways we can use that. So that's important from an ordering perspective."
Doyle also highlighted Domino's partnership with Ford to test self-driving cars for pizza delivery. Announced in August, the project will be a continuation of Domino's tech-enabled delivery experiments, which have included drone and robot delivery tests.
"[With] this relationship with Ford and the testing we've been doing on autonomous vehicles, we're figuring out new ways to deliver to people. It's going to take some time, but we're excited about it, " Doyle said.
"Why not expect some change?" he said. "Nearly half the shareholders who voted agreed with Peltz that Procter is too insular and not innovative enough when it comes to developing smaller new brands into larger established ones. That's what Peltz was pushing for in a nutshell."
Considering the millions of dollars Procter & Gamble spent to fight Peltz over the investor's desired board seat, Cramer thought it fair to expect change, particularly because the company won the vote by such a small margin.
It's probably in Procter & Gamble's interests to incite some sort of change, the "Mad Money" host said, pointing to the weakness among consumer packaged goods stocks.
In Cramer's lightning round, he shared his take on some callers' favorite stocks:
Bristol-Myers Squibb Co.: "Bristol-Myers came all the way back [and] made a new high despite the fact that it lost out in a bunch of head-to-heads against Keytruda. Look, you've got to like it. The one I've been buying for ActionAlertsPlus.com is the unfortunate Allergan, but Eli Lilly looks good. "